MedTrace Logo

Brain Dopamine Function in Adults With ADHD

NCT00580814 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2024-08-29

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to investigate the functional state of dopamine cells and the dopamine transporter in ADHD subjects and controls to assess the effects of chronic methylphenidate treatment on dopamine cell function and dopamine transporter levels in ADHD subjects.

Conditions

  • Attention Deficit Hyperactivity Disorder

Interventions

DRUG

Experimental: methylphenidate treatment

subjects received mehtylphenidate treatment for 12 months

Sponsors & Collaborators

Principal Investigators

  • Tim Wigal, Ph.D. · UC Irvine

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2009-03-31
Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00580814 on ClinicalTrials.gov